Literature DB >> 12610159

An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Amy L Harper1, Malgorzata Sudol, Michael Katzman.   

Abstract

Integrase can insert retroviral DNA into almost any site in cellular DNA; however, target site preferences are noted in vitro and in vivo. We recently demonstrated that amino acid 119, in the alpha2 helix of the central domain of the human immunodeficiency virus type 1 integrase, affected the choice of nonviral target DNA sites. We have now extended these findings to the integrases of a nonprimate lentivirus and a more distantly related alpharetrovirus. We found that substitutions at the analogous positions in visna virus integrase and Rous sarcoma virus integrase changed the target site preferences in five assays that monitor insertion into nonviral DNA. Thus, the importance of this protein residue in the selection of nonviral target DNA sites is likely to be a general property of retroviral integrases. Moreover, this amino acid might be part of the cellular DNA binding site on integrase proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610159      PMCID: PMC149511          DOI: 10.1128/jvi.77.6.3838-3845.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Mapping target site selection for the non-specific nuclease activities of retroviral integrase.

Authors:  M Katzman; M Sudol; J S Pufnock; S Zeto; L M Skinner
Journal:  Virus Res       Date:  2000-01       Impact factor: 3.303

Review 2.  Molecular genetics and target site specificity of retroviral integration.

Authors:  M L Holmes-Son; R S Appa; S A Chow
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

Review 3.  Integration site selection by lentiviruses: biology and possible control.

Authors:  F D Bushman
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

4.  Role of the nonspecific DNA-binding region and alpha helices within the core domain of retroviral integrase in selecting target DNA sites for integration.

Authors:  R S Appa; C G Shin; P Lee; S A Chow
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

5.  Natural selection results in conservation of HIV-1 integrase activity despite sequence variability.

Authors:  R Reinke; N R Steffen; W E Robinson
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

6.  Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases.

Authors:  L M Skinner; M Sudol; A L Harper; M Katzman
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

8.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.

Authors:  M Katzman; A L Harper; M Sudol; L M Skinner; M E Eyster
Journal:  J Acquir Immune Defic Syndr       Date:  2001-11-01       Impact factor: 3.731

10.  The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.

Authors:  G Bujacz; M Jaskólski; J Alexandratos; A Wlodawer; G Merkel; R A Katz; A M Skalka
Journal:  Structure       Date:  1996-01-15       Impact factor: 5.006

View more
  25 in total

1.  Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.

Authors:  Mark A Brockman; Denis R Chopera; Alex Olvera; Chanson J Brumme; Jennifer Sela; Tristan J Markle; Eric Martin; Jonathan M Carlson; Anh Q Le; Rachel McGovern; Peter K Cheung; Anthony D Kelleher; Heiko Jessen; Martin Markowitz; Eric Rosenberg; Nicole Frahm; Jorge Sanchez; Simon Mallal; Mina John; P Richard Harrigan; David Heckerman; Christian Brander; Bruce D Walker; Zabrina L Brumme
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

2.  Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA capture.

Authors:  Tracy L Diamond; Frederic D Bushman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Authors:  Malgorzata Sudol; Jennifer L Fritz; Melissa Tran; Gavin P Robertson; Julie B Ealy; Michael Katzman
Journal:  Antivir Chem Chemother       Date:  2011-10-07

Review 4.  Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses.

Authors:  Ga-Eun Lee; Eric Mauro; Vincent Parissi; Cha-Gyun Shin; Paul Lesbats
Journal:  Viruses       Date:  2019-08-22       Impact factor: 5.048

5.  A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Authors:  Wesley M Konsavage; Stephen Burkholder; Malgorzata Sudol; Amy L Harper; Michael Katzman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 6.  Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C.

Authors:  Kunkai Su; Dan Wang; Jian Ye; Yun C Kim; Samson A Chow
Journal:  Methods       Date:  2009-01-30       Impact factor: 3.608

7.  Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.

Authors:  J-Y Métais; S Topp; R T Doty; B Borate; A-D Nguyen; T G Wolfsberg; J L Abkowitz; C E Dunbar
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

8.  Inhibition of human immunodeficiency virus type 1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate.

Authors:  Krishan K Pandey; Sibes Bera; Jacob Zahm; Ajaykumar Vora; Kara Stillmock; Daria Hazuda; Duane P Grandgenett
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Alternative nucleophilic substrates for the endonuclease activities of human immunodeficiency virus type 1 integrase.

Authors:  Julie B Ealy; Malgorzata Sudol; Jacek Krzeminski; Shantu Amin; Michael Katzman
Journal:  Virology       Date:  2012-08-19       Impact factor: 3.616

10.  Structural basis for functional tetramerization of lentiviral integrase.

Authors:  Stephen Hare; Francesca Di Nunzio; Alfred Labeja; Jimin Wang; Alan Engelman; Peter Cherepanov
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.